Bone cement company blamed for multiple deaths, accused of human experimentation.
A history of patient deaths.
One woman, who had injured her back after she fell two floors while creating an addition to her house, suffered from severe bleeding and blood clots during surgery. She died on the operating table in 2007. Another patient had suffered from back problems since a previous car accident. She also bled out during surgery, and the medical team was unable to save her.
There were a minimum of three other patients who had undergone spinal surgery before these two patients, who also died after the bone cement was injected into their spines. The problem was that some of the material leaked into their bloodstreams, which caused clotting.
Lack of information.
These patients, treated with the NoriaN® bone cement, were never told that the FDA had not approved it for use in spinal surgery. Instead of being honest with the patients, the manufacturer and its parent company allegedly conspired with surgeons to engage in “human experimentation.” According to federal prosecutors, they were attempting to avoid the lengthy and costly regulatory process.
Norian is no stranger to lawsuits and was sued in 2012 in a wrongful death and negligence lawsuit. The lawsuit was the result of the death of a 70-year-old woman who died after back surgery in 2003. During the surgery, bone cement was injected into the woman’s spine in the presence of a sales representative for the manufacturer. The woman died after some of the product leaked into her blood and caused clotting. The companies never filed a report with the FDA and told the family, “She didn’t make it.” The family later settled their lawsuit with Synthes and Norian through private mediation.
Legal ramifications.
In 2009, Norian, its parent company Synthes, and four top executives faced an indictment for their choice to conduct clinical trials without permission. It did this despite being warned that the bone cement was known to cause blood clots. The indictment led to a $22.5 million penalty and a $669,800 fine; the executives received prison terms.
Norian’s parent company bought the corporation, which previously developed bone cements for other surgical uses. They intended to alter the original product for its use in spinal surgeries. Because the FDA approval process was quite long, they allegedly opted to perform approximately 60-80 spinal surgeries using the Norian bone cement, after which they would publish clinical results. According to court documents, the company recruited a team of surgeons to test the product on patients.
By 2006, the FDA had approved a cement called Norian CRS, but it required labeling to indicate that it was NOT to be used in spinal surgeries. The parent company notified surgeons of this restriction in 2007. However, court records show that at least one surgeon continued using Norian despite the FDA restrictions and previous deaths that resulted from the use of the cement in spinal surgery.
Has your family lost a loved one due to complications surrounding the use of bone cement to treat a spinal injury? Call Rasansky | McKenzie Law today at (214) 651-6100 to find out how we can help you seek justice.